Category Archives: Uncategorized

Mallinckrodt v. Praxair – Innomax Method Patent Fails Alice/Mayo Test

On Tuesday, a Delaware district court judge ruled that a group of Mallinckrodt patents failed the Alice/(mostly)Mayo test as claiming a natural phenomenon. The patents are directed to a method of safely using the Innomax system, which administers nitric oxide to infants … Continue reading

Posted in Alice, Federal Court, Uncategorized | 1 Comment

Athena Diagnostics v. Mayo – Finessing the Correlations Trap?

In The Cleveland Clinic Foundation v. True Health Diagnostics, the Fed. Cir. panel held that a claim to a diagnostic method for determining a test subject’s risk for atherosclerotic cardiovascular disease (CD) by comparing MPO levels in the bodily fluid … Continue reading

Posted in Federal Court, Section 101, Uncategorized | 1 Comment

Millennium Pharm. v. Sandoz, Inc. – Revenge of the Chemical Judges

In the 2003 panel decision in Schering Corp. v. Geneva Pharm., Inc., the panel rejected “the contention that inherent anticipation requires recognition [of the claim element not found] in the prior art.” The claims were directed to a bioactive metabolite … Continue reading

Posted in Federal Court, Uncategorized | 1 Comment

Patent Office Releases Comments on Standards for Patent Eligibility Examination

On November 2nd, Robert Bahr released a concise but informative memorandum that could be entitled “What We Learned From McRO and BASCOM.” I have posted on McRO, Inc. dba Planet Blue v. Bandi Namco Games America Inc. et al., 120 … Continue reading

Posted in Claim Construction, Federal Court, Govt Policy/PTO Policy, Uncategorized, USPTO Practice and Policy | Leave a comment